Last reviewed · How we verify

NCT03566433

Postoperative Pain After Endoscopic TEP vs. Lichtenstein Hernioplasty in Inguinal Hernia Repair

Completed NA Last updated 1 November 2021
What this trial tests

NA trial testing Tep surgery for inguinal hernia in Inguinal Hernia in 200 participants. Completed in 31 May 2020.

Timeline
1 November 2017
Primary endpoint
31 December 2019
31 May 2020

Quick facts

Lead sponsorKuopio University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment200
Start date1 November 2017
Primary completion31 December 2019
Estimated completion31 May 2020
Sites1 location across Finland

Drugs / interventions tested

Conditions studied

Sponsor

Kuopio University Hospital

Who can join

Adults 18 to 80, any sex, with Inguinal Hernia or Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Immediate pain reaction and return to work after TEP or Lichtenstein hernia repair have not been studied. In this multicenter trial the patients are allocated to surgery using TEP (n=50) or Lichtenstein (n=50) technique. Pain and return to work are recorded postoperatively up to one month. Immediate and late complications are also analyzed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A randomized clinical trial comparing early patient-reported pain after open anterior mesh repair versus totally extraperitoneal repair of inguinal hernia.
    Matikainen M, Vironen JH, Silvasti S, Ilves I, et al · · 2021 · cited 6× · PMID 34791044 · DOI 10.1093/bjs/znab354

Verify or expand the search:

Other recruiting trials for Inguinal Hernia

Currently open trials in the same condition.

Other Kuopio University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03566433.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing